Treatment Patterns Among Early Inclisiran vs Anti–PCSK9 mAbs Users: A Retrospective Analysis of US Claims Databases
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The results of those 2 studies suggested that inclisiran could be an alternative to enhance adherence.
“Although their follow-up ≤1 year, the results suggested that inclisiran could be an alternative to enhance adherence.86,91”
From Adherence to PCSK9 Inhibitors in Clinical Practice (2026) · cites this paper as [91]
Cited by
Sorted by citations
Adherence to PCSK9 Inhibitors in Clinical Practice
Blais, J. E., Zhong, W., Li, C. Y. V., Kongkaew, C., & Chan, A. H. Y. (2026) · JACC: Advances · doi:10.1016/j.jacadv.2026.102733 · Cited by 7 · see citing works
- Authors
- Popadic, L., Ma, X., Ali, Y., Kumparatana, P., Wei, Y., McElligott, S., & Niu, X.
- Venue
- Journal of Clinical Lipidology
- Publisher
- Elsevier BV
- Published
- 2024-07
- Volume
- 18
- Issue
- 4
- Pages
- e515-e516
- ISSN
- 1876-4789 (ISSN-L)
- 1933-2874
- OpenAlex
- W4400959357
- Cited by
- 8
- References
- 0
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 1
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of clinical lipidology (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- Keywords
- inclisiran, PCSK9 inhibitors, alirocumab, evolocumab, medication adherence, treatment persistence, drug discontinuation, LDL cholesterol lowering, primary hyperlipidemia, statin therapy, proportion of days covered, dosing regimen, real-world treatment patterns, claims data, Novartis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
